Please assess the completion status of the following clinical trial:

Trial Title: [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of type 1 or 2 diabetes mellitus, with painful, distal, symmetrical, sensorimotor polyneuropathy~* Patients at screening must have a score \>/=40 mm on the pain visual analogue scale~Exclusion Criteria:~* Patients with significant hepatic impairment~* Patients with other severe pain, that may impair the self-assessment of the pain due to DPN

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Open Treatment (Type: EXPERIMENTAL): \[S,S\]-reboxetine
- Standard Care (Type: OTHER): Standard Care

Based on this trial design, predict the completion outcome and termination type (if applicable).